Yi Wang
Impact in
- Immunology top 1%
- Immune cells in cancer
- interferon and immune responses
- Immune Cell Function and Interaction
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
Papers in
-
- RNA modifications and cancer 21
- Immunology 68
- Immune cells in cancer 21
- interferon and immune responses 17
- Co-authors
- Hailian Wang (20 shared papers)Suya Du (11 shared papers)Tiantian Lei (15 shared papers)Rongsheng Tong (9 shared papers)Xia He (8 shared papers)Xin‐Yuan Guan (3 shared papers)Jonathan S. T. Sham (2 shared papers)Shaoping Deng (17 shared papers)
- Journals
- Frontiers in Immunology (16 papers)International Journal of Molecular Medicine (9 papers)Xenotransplantation (8 papers)Scientific Reports (7 papers)Frontiers in Pharmacology (7 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Yi Wang
428 papers receiving 9.2k citations
Yi Wang's Hit Papers
Peers
Comparison fields: 5 of 166
- Immunology 1.7k
- Cancer Research 1.1k
- Complementary and alternative medicine 452
- Molecular Biology 3.2k
- Oncology 942
Countries citing papers authored by Yi Wang
This map shows the geographic impact of Yi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Wang more than expected).
Fields of papers citing papers by Yi Wang
This network shows the impact of papers produced by Yi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Wang. The network helps show where Yi Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 457 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 240 | |
| 2 | 2018 | 198 | |
| 3 | 2002 | 179 | |
| 4 | An Overview: The Diversified Role of Mitochondria in Cancer Metabolism Hit paper breakdown → | 2023 | 159 |
| 5 | TREM2+ macrophages suppress CD8+ T-cell infiltration after transarterial chemoembolisation in hepatocellular carcinoma Hit paper breakdown → | 2023 | 139 |
| 6 | 2019 | 125 | |
| 7 | 2016 | 115 | |
| 8 | 2008 | 113 | |
| 9 | 2018 | 113 | |
| 10 | 2012 | 113 | |
| 11 | 2019 | 112 | |
| 12 | 2013 | 108 | |
| 13 | 2007 | 107 | |
| 14 | 1987 | 106 | |
| 15 | 2015 | 102 | |
| 16 | 2022 | 100 | |
| 17 | 2009 | 96 | |
| 18 | 2017 | 96 | |
| 19 | 2022 | 93 | |
| 20 | 2017 | 93 |
About Yi Wang
Yi Wang is a scholar working on Molecular Biology, Immunology, Surgery, Cancer Research and Epidemiology, having authored 457 papers that have together received 9.3k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (25 papers), RNA modifications and cancer (21 papers), Immune cells in cancer (21 papers), interferon and immune responses (17 papers), Xenotransplantation and immune response (15 papers), Cancer, Hypoxia, and Metabolism (15 papers), Autophagy in Disease and Therapy (13 papers) and Esophageal Cancer Research and Treatment (13 papers). The work is most often cited by research in Immunology (1.7k citations), Cancer Research (1.1k citations), Complementary and alternative medicine (452 citations), Molecular Biology (3.2k citations) and Oncology (942 citations). Yi Wang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Hailian Wang, Suya Du, Tiantian Lei, Rongsheng Tong, Xia He, Xin‐Yuan Guan, Jonathan S. T. Sham, Shaoping Deng, Yue Liu and Chunyang Jia. Their work appears in journals such as Frontiers in Immunology, International Journal of Molecular Medicine, Xenotransplantation, Scientific Reports and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.